Salicylic Acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot and disrupt the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely. A small amount of the wart remover should then be applied using the provided applicator, ensuring that each wart is sufficiently covered.

This application should be allowed to dry, and the procedure may be repeated once or twice daily. Treatment can continue until the wart is removed, with a maximum duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist, due to the potential for adverse effects.

Application is contraindicated on irritated, infected, or reddened skin to prevent exacerbation of these conditions.

The product should not be applied to genital warts or warts located on the face, as these areas may require specialized treatment.

Use is also contraindicated on moles, birthmarks, and warts with hair growing from them to avoid potential complications.

Additionally, the product must not be used on mucous membranes, as this may lead to irritation or other adverse reactions.

Warnings and Precautions

For external use only, this product is flammable and should be kept away from fire or flame. It is essential to cap the bottle tightly and store it at room temperature, away from heat sources.

This product is contraindicated for individuals with diabetes or poor blood circulation unless used under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. It should not be applied to irritated, infected, or reddened skin, nor should it be used on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, it must not be applied to mucous membranes.

When using this product, care should be taken to avoid contact with the eyes. In the event of contact, it is crucial to flush the eyes with water for at least 15 minutes. Inhalation of vapors should also be avoided to prevent respiratory irritation.

If discomfort persists after use, it is advised to discontinue use and consult a healthcare professional. This product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients should be aware that the product is for external use only. It is contraindicated for individuals who are diabetic or have poor blood circulation, unless used under the advice and supervision of a doctor or podiatrist. The product should not be applied to irritated, infected, or reddened skin, nor should it be used on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, it should not be applied to mucous membranes.

While using the product, patients are advised to avoid contact with the eyes. In the event of contact, the eyes should be flushed with water for 15 minutes. Inhalation of vapors should also be avoided to prevent respiratory discomfort.

Patients should discontinue use and consult a doctor if discomfort persists. It is crucial to keep the product out of reach of children. If swallowed, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (liquid wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The safety of salicylic acid during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in this population. Consequently, the potential risks to fetal outcomes remain unclear. Healthcare professionals should exercise caution when considering the use of salicylic acid in pregnant patients, as the absence of safety data necessitates a careful evaluation of the benefits versus potential risks. Women of childbearing potential should be advised to discuss their pregnancy status and any plans for pregnancy with their healthcare provider before using this medication.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that this product should not be used by individuals who are diabetic or have poor blood circulation unless under the guidance and supervision of a healthcare professional, such as a doctor or podiatrist.

Patients should be cautioned against using the product on irritated, infected, or reddened skin, as well as on genital warts and warts located on the face. Additionally, the product should not be applied to moles, birthmarks, or warts that have hair growing from them, nor should it be used on mucous membranes.

Healthcare providers should instruct patients to discontinue use and consult a doctor if discomfort persists. It is also essential to emphasize the importance of avoiding contact with the eyes while using this product. In the event that the product comes into contact with the eyes, patients should be advised to flush the eyes with water for 15 minutes. Furthermore, patients should be warned to avoid inhaling vapors while using the product.

Storage and Handling

The product is supplied in a tightly capped bottle. It is essential to store the bottle at room temperature, ensuring it is kept away from heat sources. The recommended storage temperature range is between 20°C to 30°C (68°F to 86°F). Additionally, it is crucial to keep the product away from fire or flame to ensure safety and integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)